|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1997-10-1
|
|
pubmed:abstractText |
Recent studies have suggested that recombinant interferon gamma (IFNg) may be useful in the treatment of various respiratory diseases, such as chronic inflammatory disease. This study was undertaken to investigate the dose response of escalating doses of inhaled 123I-labeled IFNg (123I-IFNg) and its safety, biodistribution and radiation absorbed doses in healthy volunteers.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
38
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1475-81
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9293812-Administration, Inhalation,
pubmed-meshheading:9293812-Female,
pubmed-meshheading:9293812-Half-Life,
pubmed-meshheading:9293812-Humans,
pubmed-meshheading:9293812-Interferon-gamma,
pubmed-meshheading:9293812-Iodine Radioisotopes,
pubmed-meshheading:9293812-Lung,
pubmed-meshheading:9293812-Male,
pubmed-meshheading:9293812-Middle Aged,
pubmed-meshheading:9293812-Nebulizers and Vaporizers,
pubmed-meshheading:9293812-Recombinant Proteins,
pubmed-meshheading:9293812-Reference Values
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Inhalation scintigraphy with iodine-123-labeled interferon gamma-1b: pulmonary deposition and dose escalation study in healthy volunteers.
|
|
pubmed:affiliation |
Department of Clinical Pharmacology, University of Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article
|
